Syngene International Ltd

Syngene International Earnings Call Transcript: Key Takeaways

Syngene reports a transitional quarter with sequential recovery but YoY declines due to the absence of the large Librela revenue stream.

Syngene International Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs 833 Cr (down 9% YoY, up 13% QoQ). Operating EBITDA margin 18% on forex hedge losses. PAT before exceptionals Rs 38 Cr (down 44% YoY). Focus on integrated CRDMO and first Bayview biologics deal.

Syngene International Results Update

Syngene reported Q2 FY27 revenue of Rs 833 Crore, up 13% sequentially, with PAT of Rs 32 Crore. Release includes P&L highlights and business updates.

Syngene International Management Change

Syngene reports changes in senior management: two heads move from SMP to Non-SMP, Ajay Tandon resigns effective October 30, 2026, and CFO Deepak Jain plans to leave. The CFO is a KMP, so this is a material leadership change.

Syngene International Q2 FY27 Results: Net Profit ₹32.2 Cr, Down 52.0% YoY

Syngene International Ltd reported revenue from operations of ₹832.7 Cr (-8.6% YoY) and net profit of ₹32.2 Cr (-52.0% YoY) for Q2 FY27.

Key figure

Net profit ₹32.2 Cr · -52.0% YoY